Ashworth, Alan
Lord, Christopher J.
Article History
First Online: 28 June 2018
Competing interests
: A.A. is or has been a consultant of AtlasMDX, Bluestar, Driver, Genentech, Pfizer, Prolynx, Sun Pharma and Third Rock Ventures; has received research support from Sun Pharma; is the co-founder of Tango Therapeutics; and holds patents on the use of poly(ADP-ribose) polymerase (PARP) inhibitors jointly with AstraZeneca, from which he has benefited financially (and may do so in the future) through the Institute of Cancer Research Rewards to Inventors scheme. C.J.L. is or has been a consultant of AstraZeneca, GLG, Guidepoint, Sun Pharma, Third Rock Ventures and Vertex; has received research support from AstraZeneca and Merck KGaA; and holds patents on the use of DNA repair inhibitors and stands to gain from their use as part of the Institute of Cancer Research Rewards to Inventors scheme.